Moreover, several studies also demonstrated the Akt/mTOR signaling pathway was a promising therapeutic candidate for chronic prostatitis (Zhan, Chen et al., 2020; Zhang, Yu et al., 2020). Here, AKT1 is linked to prostatitis.